A Normal Tryptase Result Doesn't Close the Question

Tryptase is a mast-cell enzyme in the blood, and one number does not diagnose MCAS. Most children with MCAS have a normal baseline tryptase. What matters is the comparison between a level drawn during a flare and that child's own baseline — not whether a single result fell inside the lab's reference range.

Emergency care first. Trouble breathing, swelling of the lips, tongue, or throat, collapse, or a drop in blood pressure is anaphylaxis. Use epinephrine if it has been prescribed, then call 911. Nothing on this page is a reason to wait and see.

This is the result that most often gets misread in both directions. A normal number gets treated as proof nothing is happening. A high number gets treated as proof of MCAS. Neither follows.

What tryptase is

Tryptase is an enzyme stored in mast cell granules and released when mast cells activate. It is the most specific blood marker available for mast cell involvement, which is why it appears in the diagnostic criteria at all.

Two measurements matter, and they answer different questions:

• Baseline tryptase — drawn on a well day, at least 24 hours after any reaction. This reflects how many mast cells a person has, not whether they are currently activating.
• Acute tryptase — drawn during or shortly after a flare, generally within a few hours. This reflects activation.

A single tryptase, drawn at a routine visit, is a baseline. It was never designed to answer whether a reaction three weeks ago was mast cell mediated.

Can tryptase be normal and still be MCAS?

Yes. Most children with MCAS have a normal baseline tryptase.

This is the single most useful sentence on this page, and the one most often missed in a general clinic. A normal baseline is the expected finding in MCAS. It does not argue against the diagnosis.

The reason is mechanical. Baseline tryptase reflects mast cell burden. In MCAS, the number of mast cells is normal — they simply activate too readily. Conditions with an increased mast cell burden, such as systemic mastocytosis, are the ones that elevate the baseline.

If someone has told you MCAS is ruled out because tryptase was normal, that conclusion does not follow from the test.

Baseline versus during a flare

A flare tryptase is judged against that child's own baseline — a rise of 1.2 times baseline plus 2 — not a single "normal" line on the printout.

That formula is the consensus criterion. Multiply the baseline by 1.2, add 2 ng/mL, and the acute level must exceed that figure to count as evidence of activation. A child with a baseline of 5 would need an acute level above 8. A child with a baseline of 10 would need one above 14.

The arithmetic scales with the individual, which is exactly the point. A fixed cutoff would miss activation in children with low baselines and overcall it in children with high ones.

Two practical consequences:

Timing decides whether the test is worth drawing. Tryptase peaks roughly an hour after a reaction begins and clears with a short half-life. Drawn the next day, it is back to baseline and the result is uninformative. The acute sample needs to happen within a few hours.

You need the baseline to interpret the flare. Without it, an acute number is a figure with nothing to compare against. If your child has episodic reactions, ask about a standing lab order so a sample can be drawn during a flare without waiting for an appointment, and make sure a well-day baseline is on file.

A negative result from a badly timed draw is not a negative result. It is a missed measurement.

Does high tryptase mean mastocytosis?

A high baseline tryptase is not typical MCAS. It points to hereditary alpha-tryptasemia or mastocytosis, which is a different workup.

Hereditary alpha-tryptasemia is a genetic trait involving extra copies of the TPSAB1 gene. It raises baseline tryptase without any mast cell disease being present, and it is common enough in the general population to be a frequent explanation for an unexpectedly high number. It is confirmed with copy number testing, and it can be associated with mast cell symptoms, dysautonomia, and connective tissue laxity.

Systemic mastocytosis involves an increased mast cell burden. A markedly elevated baseline is one of its minor diagnostic criteria, and confirming it requires a different evaluation, typically including KIT mutation testing and sometimes bone marrow examination.

Tryptase can also run high in chronic kidney disease and certain blood disorders.

So a high baseline is a finding that redirects the workup rather than confirming MCAS. It matters, and it matters differently than most families expect.

What we do with the result

We interpret it against the clinical picture, not alone. Tryptase is one of three consensus criteria. The others are symptoms in two or more organ systems and a documented response to mast-cell-directed treatment. A number without those is not a diagnosis, which we cover in flushing, hives, and tummy pain together.

We set up the timing in advance. A baseline on file and a plan for drawing during a flare, so the next episode produces usable information rather than another normal number from a badly timed draw.

We investigate a high baseline properly rather than treating it as confirmation.

We say what a normal result does and does not mean. It does not close the question.

For a broader overview of the condition, start with MCAS in teens.

Frequently asked questions

What does a tryptase test mean in a child?

Tryptase is a mast-cell enzyme in the blood, and one number does not diagnose MCAS. A baseline level drawn on a well day reflects how many mast cells a child has. An acute level drawn during a flare reflects activation. The comparison between them is what carries diagnostic meaning, not a single value.

Can tryptase be normal and still be MCAS?

Yes. Most children with MCAS have a normal baseline tryptase. Baseline reflects mast cell burden, which is normal in MCAS — the cells simply activate too readily. Conditions that raise the baseline involve an increased mast cell burden. A normal baseline does not rule out MCAS and should not end the evaluation.

What is the difference between baseline and flare tryptase?

A flare tryptase is judged against that child's own baseline — a rise of 1.2 times baseline plus 2 — not a single "normal" line on the printout. Baseline is drawn on a well day at least 24 hours after a reaction. The acute sample must be drawn within a few hours of a flare, because tryptase peaks early and clears quickly.

Does high tryptase mean mastocytosis?

A high baseline tryptase is not typical MCAS. It points to hereditary alpha-tryptasemia or mastocytosis, which is a different workup. Hereditary alpha-tryptasemia involves extra copies of the TPSAB1 gene and raises baseline without mast cell disease. Systemic mastocytosis involves increased mast cell burden and requires separate evaluation.

Medically reviewed by

Natalie Hernandez, MD — Pediatric endocrinologist at LIFE Pediatric Endocrinology. Board certified in Pediatrics; board eligible in Pediatric Endocrinology. Fellowship at Duke University Hospital. Dr. Hernandez cares for children and teens with mast cell activation and dysautonomia alongside her metabolic practice. Full profile →

Toni Kim, MD — Founder, LIFE Pediatric Endocrinology. Board-certified pediatric endocrinologist with more than twenty years of clinical experience. Full profile →

Make the lab result mean something

A tryptase drawn at the wrong moment answers nothing. Getting a baseline on file and a plan for the next flare is what turns the next episode into information.

Start with a 15-minute consult. Book one here →

Medical disclaimer

If your child is having a medical emergency, call 911 or go to the nearest emergency department. Do not wait for a reply to a message or for an appointment.

This article is published by LIFE Pediatric Endocrinology for general educational purposes only. It is not medical advice and is not a substitute for evaluation, diagnosis, or treatment by a qualified healthcare professional who has examined your child and knows their history. Reading it does not create a physician-patient relationship with LIFE Pediatric Endocrinology or any of its physicians.

Never disregard professional medical advice, or delay seeking it, because of something you have read here. Do not start, stop, or change any medication, dose, or treatment based on this article. Every child is different, and general information cannot account for your child's specific circumstances.

Medicine changes. Guidelines, drug approvals, diagnostic criteria, and coverage rules described here were accurate to the best of our knowledge at the time of writing and may have changed since. Laboratory reference ranges vary between laboratories. References to research, guidelines, or outside organizations are provided for information only and do not imply endorsement.

Individual results vary. Nothing here is a promise or guarantee of any particular outcome.

Sources

• Valent P, et al. Definitions, criteria and global classification of mast cell disorders. International Archives of Allergy and Immunology.
• Valent P, et al. Reversible elevation of tryptase over the individual's baseline: why is it the best biomarker for severe systemic mast cell activation and MCAS?
• Gülen T, et al. Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review. J Allergy Clin Immunol Pract. 2021.
• The Mast Cell Disease Society — tests for mast cell activation
• Lyons JJ, et al. Hereditary alpha tryptasemia and TPSAB1 copy number.